The present invention is directed to cyanomethyl derivatives that are inhibitors of cysteine protease, in particular, cathepsin B, K, F, and S and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
本发明涉及
氰甲基衍
生物,其是半胱
氨酸
蛋白酶的
抑制剂,特别是对于B、K、F和S型的卡
特普辛,因此可用于治疗由这些
蛋白酶介导的疾病。本发明还涉及包含这些化合物的制药组合物和其制备过程。